Sage Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid
Sage Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid of $15.41 million as of 2024-12-31, per its 10-K filed 2025-02-11.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2025-02-11
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $15.41M.
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid $14.12M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-12-31 | $15.41M 10-K · filed 2025-02-11 |
| 2024-09-30 | $14.12M 10-Q · filed 2024-10-29 |